Blockchain Registration Transaction Record

BioMed X and Ono Pharmaceutical Co., Ltd. Collaborate on New Immunotherapy Research Team

BioMed X and Ono Pharmaceutical Co., Ltd. have partnered to establish a new research team focusing on next-generation immunotherapies, aiming to investigate the antitumor effects of neutrophils. The collaboration may lead to groundbreaking treatments for cancer patients, impacting the future of cancer treatment.

BioMed X and Ono Pharmaceutical Co., Ltd. Collaborate on New Immunotherapy Research Team

This news matters as it highlights the collaboration between BioMed X and Ono Pharmaceutical to conduct groundbreaking research on next-generation immunotherapies, offering potential breakthroughs in cancer treatment. The partnership may lead to the development of more effective therapies for cancer patients, impacting the future of cancer treatment.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x7d14628bd711616e26ae0425ca4ccfbc42aaf0f3f432f68bfa7b937f17a651ed
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintwarpkK6n-8b0ce706d098a59d9f02146296866f95